Evidence map›Paper›PMID 26261382›Full record

Observational studyMedical archives (Sarajevo, Bosnia and Herzegovina)2015

Hyperglycemia in Critically Ill Patients: Management and Prognosis.

Amina Godinjak, Amer Iglica, Azra Burekovic, Selma Jusufovic, Anes Ajanovic, Ira Tancica, Adis Kukuljac

Abstract readObservational Study
In one paragraph

Observational study in Medical archives (Sarajevo, Bosnia and Herzegovina), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Nonlinear relationship between mean amplitude of glycemic excursion and mortality in critically ill stroke patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amina GodinjakMedical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Amer IglicaMedical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Azra BurekovicClinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Selma JusufovicMedical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Anes AjanovicMedical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Ira TancicaMedical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Adis KukuljacMedical Intensive Care Unit, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
University of Sarajevo · BAClinical Center University of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHyperglycemia is a common complication of critical illness. Patients in intensive care unit with stress hyperglycemia have significantly higher mortality (31%) compared to patients with previously confirmed diabetes (10%) or normoglycemia (11.3%). Stress hyperglycemia is associated with increased risk of critical illness polyneuropathy (CIP) and prolonged mechanical ventilation. Intensive monitoring and insulin therapy according to the protocol are an important part of the treatment of critically ill patients.

objectiveTo evaluate the incidence of stress hyperglycemia, complications and outcome in critically ill patients in our Medical intensive care unit. MATERIALS AND

methodsThis study included 100 patients hospitalized in Medical intensive care unit during the period January 2014-March 2015 which were divided into three groups: Diabetes mellitus, stress-hyperglycemia and normoglycemia. During the retrospective-prospective observational clinical investigation the following data was obtained: age, gender, SAPS, admission diagnosis, average daily blood glucose, highest blood glucose level, glycemic variability, vasopressor and corticosteroid therapy, days on mechanical ventilation, total days of hospitalization in Medical intensive care unit, and outcome.

resultsPatients with DM treated with a continuous insulin infusion did not have significantly more complications than patients with normoglycemia, unlike patients with stress hyperglycemia, which had more severe prognosis. There was a significant difference between the maximum level of blood glucose in recovered and patients with adverse outcome (p = 0.0277). Glycemic variability (difference between max. and min. blood glucose) was the strongest predictor of adverse outcome. The difference in glycemic variability between the stress-hyperglycemia and normoglycemic group was statistically significant (p = 0.0066). There was no statistically significant difference in duration of mechanical ventilation and total days of hospitalization in the intensive care unit between the groups.

conclusionUnderstanding of the objectives of glucose regulation and effective glycemic control is essential for the proper optimization of patient outcomes.

Indexed as

AdultAgedAged, 80 and overCritical IllnessDiabetes ComplicationsFemaleHumansHyperglycemiaInsulinIntensive Care UnitsMaleMiddle AgedPrognosisYoung AdultInsulincritical illnesshyperglycemia

Identifiers

PMID26261382
PMCPMC4500381
OpenAlexW1512683643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.